FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CCT4-ACP1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CCT4-ACP1
FusionPDB ID: 14317
FusionGDB2.0 ID: 14317
HgeneTgene
Gene symbol

CCT4

ACP1

Gene ID

10575

4706

Gene namechaperonin containing TCP1 subunit 4NADH:ubiquinone oxidoreductase subunit AB1
SynonymsCCT-DELTA|Cctd|SRBACP|ACP1|FASN2A|SDAP
Cytomap

2p15

16p12.2

Type of geneprotein-codingprotein-coding
DescriptionT-complex protein 1 subunit deltaTCP-1-deltachaperonin containing TCP1, subunit 4 (delta)chaperonin containing t-complex polypeptide 1, delta subunitstimulator of TAR RNA-bindingacyl carrier protein, mitochondrialCI-SDAPNADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDaNADH-ubiquinone oxidoreductase 9.6 kDa subunitNADH:ubiquinone oxidoreductase SDAP subunitcomplex I SDAP subunitmitochondrial acyl carrier prot
Modification date2020031320200313
UniProtAcc

P50991

Main function of 5'-partner protein: FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis (PubMed:25467444). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). The TRiC complex plays a role in the folding of actin and tubulin (Probable). {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444, ECO:0000305}.

P24666

Main function of 5'-partner protein: FUNCTION: Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates. Isoform 3 does not possess phosphatase activity.
Ensembl transtripts involved in fusion geneENST idsENST00000394440, ENST00000538252, 
ENST00000544079, ENST00000544185, 
ENST00000461540, 
ENST00000484464, 
ENST00000272065, ENST00000272067, 
ENST00000405233, ENST00000407983, 
ENST00000439645, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score10 X 12 X 4=4804 X 3 X 3=36
# samples 124
** MAII scorelog2(12/480*10)=-2
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/36*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: CCT4 [Title/Abstract] AND ACP1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CCT4 [Title/Abstract] AND ACP1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CCT4(62096574)-ACP1(271865), # samples:1
Anticipated loss of major functional domain due to fusion event.CCT4-ACP1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
CCT4-ACP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
CCT4-ACP1 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
CCT4-ACP1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:62096574/chr2:271865)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CCT4 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ACP1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000538252CCT4chr262096574-ENST00000272067ACP1chr2271865+335819453551995546
ENST00000538252CCT4chr262096574-ENST00000272065ACP1chr2271865+335819453551995546
ENST00000538252CCT4chr262096574-ENST00000407983ACP1chr2271865+254019453551995546
ENST00000538252CCT4chr262096574-ENST00000439645ACP1chr2271865+245819453551995546
ENST00000538252CCT4chr262096574-ENST00000405233ACP1chr2271865+301219453551995546

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000538252ENST00000272067CCT4chr262096574-ACP1chr2271865+0.0008598640.99914014
ENST00000538252ENST00000272065CCT4chr262096574-ACP1chr2271865+0.0010537120.99894625
ENST00000538252ENST00000407983CCT4chr262096574-ACP1chr2271865+0.0012803790.9987197
ENST00000538252ENST00000439645CCT4chr262096574-ACP1chr2271865+0.0010830150.998917
ENST00000538252ENST00000405233CCT4chr262096574-ACP1chr2271865+0.0008132180.9991868

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CCT4-ACP1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CCT4chr262096574ACP1chr22718651945530TETVRSILKIDDVVTFVDHPLQKQFS

Top

Potential FusionNeoAntigen Information of CCT4-ACP1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CCT4-ACP1_62096574_271865.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CCT4-ACP1chr262096574chr22718651945HLA-B38:01LKIDDVVTF0.93570.6536716
CCT4-ACP1chr262096574chr22718651945HLA-B38:02LKIDDVVTF0.92360.6782716
CCT4-ACP1chr262096574chr22718651945HLA-B15:01ILKIDDVVTF0.99980.5407616
CCT4-ACP1chr262096574chr22718651945HLA-B15:25ILKIDDVVTF0.99420.5354616
CCT4-ACP1chr262096574chr22718651945HLA-C05:09KIDDVVTF10.7617816
CCT4-ACP1chr262096574chr22718651945HLA-C08:15KIDDVVTF0.99990.8134816
CCT4-ACP1chr262096574chr22718651945HLA-C04:06KIDDVVTF0.99720.5742816
CCT4-ACP1chr262096574chr22718651945HLA-C05:09KIDDVVTFV0.99970.8092817
CCT4-ACP1chr262096574chr22718651945HLA-C04:10KIDDVVTFV0.99960.5134817
CCT4-ACP1chr262096574chr22718651945HLA-C04:07KIDDVVTFV0.99950.5307817
CCT4-ACP1chr262096574chr22718651945HLA-C08:15KIDDVVTFV0.99680.87817
CCT4-ACP1chr262096574chr22718651945HLA-C07:27LKIDDVVTF0.99550.8156716
CCT4-ACP1chr262096574chr22718651945HLA-C04:06KIDDVVTFV0.99090.6777817
CCT4-ACP1chr262096574chr22718651945HLA-C15:06KIDDVVTFV0.96980.7583817
CCT4-ACP1chr262096574chr22718651945HLA-C04:14KIDDVVTFV0.93610.5342817
CCT4-ACP1chr262096574chr22718651945HLA-C07:67LKIDDVVTF0.86570.7616716
CCT4-ACP1chr262096574chr22718651945HLA-C07:80LKIDDVVTF0.86570.7616716
CCT4-ACP1chr262096574chr22718651945HLA-C07:46LKIDDVVTF0.86450.6112716
CCT4-ACP1chr262096574chr22718651945HLA-C07:10LKIDDVVTF0.8530.839716
CCT4-ACP1chr262096574chr22718651945HLA-B15:21LKIDDVVTF0.73870.7491716
CCT4-ACP1chr262096574chr22718651945HLA-C08:04KIDDVVTFV0.70390.9335817
CCT4-ACP1chr262096574chr22718651945HLA-C08:13KIDDVVTFV0.70390.9335817
CCT4-ACP1chr262096574chr22718651945HLA-C02:06KIDDVVTFV0.5130.9262817
CCT4-ACP1chr262096574chr22718651945HLA-C08:03KIDDVVTFV0.34980.9472817
CCT4-ACP1chr262096574chr22718651945HLA-C12:16LKIDDVVTF0.24810.8395716
CCT4-ACP1chr262096574chr22718651945HLA-C04:03KIDDVVTF10.5038816
CCT4-ACP1chr262096574chr22718651945HLA-C05:01KIDDVVTF10.7617816
CCT4-ACP1chr262096574chr22718651945HLA-C08:02KIDDVVTF0.99990.8134816
CCT4-ACP1chr262096574chr22718651945HLA-C05:01KIDDVVTFV0.99970.8092817
CCT4-ACP1chr262096574chr22718651945HLA-C04:03KIDDVVTFV0.99970.5866817
CCT4-ACP1chr262096574chr22718651945HLA-C04:01KIDDVVTFV0.99950.5307817
CCT4-ACP1chr262096574chr22718651945HLA-C18:01KIDDVVTFV0.99940.5536817
CCT4-ACP1chr262096574chr22718651945HLA-C08:02KIDDVVTFV0.99680.87817
CCT4-ACP1chr262096574chr22718651945HLA-C01:03KIDDVVTFV0.9940.808817
CCT4-ACP1chr262096574chr22718651945HLA-C15:02KIDDVVTFV0.99290.823817
CCT4-ACP1chr262096574chr22718651945HLA-C04:04KIDDVVTFV0.98140.6668817
CCT4-ACP1chr262096574chr22718651945HLA-C15:05KIDDVVTFV0.98110.8225817
CCT4-ACP1chr262096574chr22718651945HLA-C07:17LKIDDVVTF0.93720.9047716
CCT4-ACP1chr262096574chr22718651945HLA-B38:05LKIDDVVTF0.93570.6536716
CCT4-ACP1chr262096574chr22718651945HLA-C07:02LKIDDVVTF0.86570.7616716
CCT4-ACP1chr262096574chr22718651945HLA-C17:01KIDDVVTFV0.79970.6765817
CCT4-ACP1chr262096574chr22718651945HLA-B48:02LKIDDVVTF0.69870.703716
CCT4-ACP1chr262096574chr22718651945HLA-B35:20LKIDDVVTF0.6660.7608716
CCT4-ACP1chr262096574chr22718651945HLA-A69:01KIDDVVTFV0.62360.5282817
CCT4-ACP1chr262096574chr22718651945HLA-B35:28LKIDDVVTF0.58650.7405716
CCT4-ACP1chr262096574chr22718651945HLA-C08:01KIDDVVTFV0.34980.9472817
CCT4-ACP1chr262096574chr22718651945HLA-B15:53LKIDDVVTF0.27560.6299716
CCT4-ACP1chr262096574chr22718651945HLA-C12:02LKIDDVVTF0.2610.859716
CCT4-ACP1chr262096574chr22718651945HLA-B18:04LKIDDVVTF0.25120.832716
CCT4-ACP1chr262096574chr22718651945HLA-B15:54LKIDDVVTF0.21810.5833716
CCT4-ACP1chr262096574chr22718651945HLA-B18:07LKIDDVVTF0.17790.766716
CCT4-ACP1chr262096574chr22718651945HLA-C07:04KIDDVVTFV0.06060.7287817
CCT4-ACP1chr262096574chr22718651945HLA-B07:13KIDDVVTFV0.03520.5062817
CCT4-ACP1chr262096574chr22718651945HLA-B15:125ILKIDDVVTF0.99980.5407616
CCT4-ACP1chr262096574chr22718651945HLA-B15:135ILKIDDVVTF0.99980.5575616
CCT4-ACP1chr262096574chr22718651945HLA-B15:24ILKIDDVVTF0.99980.5756616
CCT4-ACP1chr262096574chr22718651945HLA-B15:50ILKIDDVVTF0.99980.5645616
CCT4-ACP1chr262096574chr22718651945HLA-B15:33ILKIDDVVTF0.99980.5407616
CCT4-ACP1chr262096574chr22718651945HLA-B15:35ILKIDDVVTF0.99980.5202616
CCT4-ACP1chr262096574chr22718651945HLA-B15:34ILKIDDVVTF0.99980.5407616
CCT4-ACP1chr262096574chr22718651945HLA-B15:27ILKIDDVVTF0.99980.5634616
CCT4-ACP1chr262096574chr22718651945HLA-B15:12ILKIDDVVTF0.99930.5409616
CCT4-ACP1chr262096574chr22718651945HLA-B15:73ILKIDDVVTF0.99750.5137616
CCT4-ACP1chr262096574chr22718651945HLA-B48:02ILKIDDVVTF0.95660.5468616
CCT4-ACP1chr262096574chr22718651945HLA-B15:20ILKIDDVVTF0.94750.5839616
CCT4-ACP1chr262096574chr22718651945HLA-B48:02SILKIDDVVTF0.97110.5196516

Top

Potential FusionNeoAntigen Information of CCT4-ACP1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CCT4-ACP1_62096574_271865.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CCT4-ACP1chr262096574chr22718651945DRB1-0301RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0310RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0310VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB1-0313RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0318RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0320RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0322RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0326RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0328RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0330RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0332RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0334RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0336RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0338RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0342RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0342VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB1-0344RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0346RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0348RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0350RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0352RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0354RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-0473IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0804IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0804DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-0806TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-0810TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-0810IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0810DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-0812TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-0812IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0812DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-0822TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-0831IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0831DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-0832IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-0834IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1134IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1344IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1358TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-1381TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-1389TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-1406IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1406DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1411IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1411DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1415IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1415DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1417IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1420IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1420DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1431IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1433IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1434IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1437IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1452IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1452DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1457IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1457KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1457DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1473IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1473TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-1476RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-1476VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB1-1478TETVRSILKIDDVVT015
CCT4-ACP1chr262096574chr22718651945DRB1-1479RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB1-1479VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB1-1480IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1480DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1483IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1483DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1484IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1484DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1501IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1501KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1501DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1501LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1502IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1502KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1503IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1503KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1503DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1503LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1504IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1504KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1504DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1504LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1505IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1505KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1505DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1505LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1506IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1506KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1506DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1506LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1507IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1507KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1507DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1507LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1508IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1508KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1509IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1509KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1509DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1509LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1510IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1510KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1510DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1510LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1511IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1511KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1512IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1512KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1512DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1512LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1513IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1513KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1513DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1513LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1514IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1514KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1515IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1515KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1516IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1516KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1516DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1516LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1518IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1518KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1518DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1518LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1519IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1519KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1520IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1520KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1520DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1520LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1521IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1521KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1521DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1521LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1522IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1522KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1522DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1522LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1523IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1523KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1523DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1523LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1524IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1524KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1524DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1524LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1525IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1525KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1526IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1526KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1527IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1527KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1528IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1528KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1528DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1528LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1529IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1529KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1529DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1529LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1530IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1530KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1530DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1531IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1531KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1532IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1532KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1532DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1532LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1533IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1533KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1533DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1533LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1534IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1535IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1535KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1535DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1535LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1536IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1536KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1536DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1536LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1537IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1537KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1537DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1537LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1538IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1538KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1539IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1539KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1540IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1540KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1540DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1540LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1541IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1541KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1541DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1541LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1542IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1542KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1542DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1542LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1543IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1543KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1543DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1543LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1544IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1544KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1545IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1545KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1545DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1545LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1546IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1546KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1546DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1546LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1547IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1547KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1548IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1548KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1548DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1548LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1549IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1549KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1549DDVVTFVDHPLQKQF1025
CCT4-ACP1chr262096574chr22718651945DRB1-1549LKIDDVVTFVDHPLQ722
CCT4-ACP1chr262096574chr22718651945DRB1-1602IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1605IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1607IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1610IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1611IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1614IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1615IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB1-1615KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB1-1616IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB3-0101RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0101VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0104RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0104VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0105RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0105VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0108RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0108VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0111RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0111VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0112RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0112VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0113RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0113VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB3-0114RSILKIDDVVTFVDH419
CCT4-ACP1chr262096574chr22718651945DRB3-0114VRSILKIDDVVTFVD318
CCT4-ACP1chr262096574chr22718651945DRB5-0202IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB5-0202KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB5-0204IDDVVTFVDHPLQKQ924
CCT4-ACP1chr262096574chr22718651945DRB5-0204KIDDVVTFVDHPLQK823
CCT4-ACP1chr262096574chr22718651945DRB5-0205IDDVVTFVDHPLQKQ924

Top

Fusion breakpoint peptide structures of CCT4-ACP1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3791ILKIDDVVTFVDHPCCT4ACP1chr262096574chr22718651945

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CCT4-ACP1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3791ILKIDDVVTFVDHP-7.9962-8.1096
HLA-B14:023BVN3791ILKIDDVVTFVDHP-5.70842-6.74372
HLA-B52:013W393791ILKIDDVVTFVDHP-6.83737-6.95077
HLA-B52:013W393791ILKIDDVVTFVDHP-4.4836-5.5189
HLA-A11:014UQ23791ILKIDDVVTFVDHP-10.0067-10.1201
HLA-A11:014UQ23791ILKIDDVVTFVDHP-9.03915-10.0745
HLA-A24:025HGA3791ILKIDDVVTFVDHP-6.56204-6.67544
HLA-A24:025HGA3791ILKIDDVVTFVDHP-5.42271-6.45801
HLA-B44:053DX83791ILKIDDVVTFVDHP-7.85648-8.89178
HLA-B44:053DX83791ILKIDDVVTFVDHP-5.3978-5.5112
HLA-A02:016TDR3791ILKIDDVVTFVDHP-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of CCT4-ACP1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CCT4-ACP1chr262096574chr2271865516SILKIDDVVTFAGCATTCTGAAAATAGATGATGTGGTAACATTT
CCT4-ACP1chr262096574chr2271865616ILKIDDVVTFATTCTGAAAATAGATGATGTGGTAACATTT
CCT4-ACP1chr262096574chr2271865716LKIDDVVTFCTGAAAATAGATGATGTGGTAACATTT
CCT4-ACP1chr262096574chr2271865816KIDDVVTFAAAATAGATGATGTGGTAACATTT
CCT4-ACP1chr262096574chr2271865817KIDDVVTFVAAAATAGATGATGTGGTAACATTTGTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CCT4-ACP1chr262096574chr2271865015TETVRSILKIDDVVTACTGAAACTGTTCGGAGCATTCTGAAAATAGATGATGTGGTAACA
CCT4-ACP1chr262096574chr22718651025DDVVTFVDHPLQKQFGATGATGTGGTAACATTTGTCGATCACCCATTGCAGAAGCAGTTT
CCT4-ACP1chr262096574chr2271865318VRSILKIDDVVTFVDGTTCGGAGCATTCTGAAAATAGATGATGTGGTAACATTTGTCGAT
CCT4-ACP1chr262096574chr2271865419RSILKIDDVVTFVDHCGGAGCATTCTGAAAATAGATGATGTGGTAACATTTGTCGATCAC
CCT4-ACP1chr262096574chr2271865722LKIDDVVTFVDHPLQCTGAAAATAGATGATGTGGTAACATTTGTCGATCACCCATTGCAG
CCT4-ACP1chr262096574chr2271865823KIDDVVTFVDHPLQKAAAATAGATGATGTGGTAACATTTGTCGATCACCCATTGCAGAAG
CCT4-ACP1chr262096574chr2271865924IDDVVTFVDHPLQKQATAGATGATGTGGTAACATTTGTCGATCACCCATTGCAGAAGCAG

Top

Information of the samples that have these potential fusion neoantigens of CCT4-ACP1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
OVCCT4-ACP1chr262096574ENST00000538252chr2271865ENST00000272065TCGA-13-1403

Top

Potential target of CAR-T therapy development for CCT4-ACP1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CCT4-ACP1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CCT4-ACP1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource